img

Global Herpes Zoster Infection Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Herpes Zoster Infection Treatment Market Research Report 2024

Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many years after the occurrence of chicken pox infection and is as reactive as Herpes Zoster.
According to MRAResearch’s new survey, global Herpes Zoster Infection Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Herpes Zoster Infection Treatment market research.
Chickenpox is caused by initial infection of VZV virus, after chicken pox is resolved the virus remains inactive in the nerve cells. The virus gets reactive travels to the nerve end producing blisters. The rash increases within two or three weeks. Herpes zoster appear as blisters on one side of the body usually on neck, face or torso. Some symptoms beyond pain and rashes are fever, headache, fatigue and muscles weakness. Person who had chicken pox is at risk of herpes zoster. The person with the herpes zoster can pass on the virus to someone else who never had chicken pox, but the person will develop chicken pox and not herpes zoster.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Herpes Zoster Infection Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bausch Health
Camber Pharmaceuticals
Novartis
Teva Pharmaceutical
Abbott
Merck
Segment by Type
Oral
Topical

Segment by Application


Clinics
Hospitals
Diagnostic centers
Home Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Herpes Zoster Infection Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Zoster Infection Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral
1.2.3 Topical
1.3 Market by Application
1.3.1 Global Herpes Zoster Infection Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Diagnostic centers
1.3.5 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Herpes Zoster Infection Treatment Market Perspective (2018-2033)
2.2 Herpes Zoster Infection Treatment Growth Trends by Region
2.2.1 Global Herpes Zoster Infection Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Herpes Zoster Infection Treatment Historic Market Size by Region (2018-2023)
2.2.3 Herpes Zoster Infection Treatment Forecasted Market Size by Region (2024-2033)
2.3 Herpes Zoster Infection Treatment Market Dynamics
2.3.1 Herpes Zoster Infection Treatment Industry Trends
2.3.2 Herpes Zoster Infection Treatment Market Drivers
2.3.3 Herpes Zoster Infection Treatment Market Challenges
2.3.4 Herpes Zoster Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Herpes Zoster Infection Treatment Players by Revenue
3.1.1 Global Top Herpes Zoster Infection Treatment Players by Revenue (2018-2023)
3.1.2 Global Herpes Zoster Infection Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Herpes Zoster Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Herpes Zoster Infection Treatment Revenue
3.4 Global Herpes Zoster Infection Treatment Market Concentration Ratio
3.4.1 Global Herpes Zoster Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Zoster Infection Treatment Revenue in 2022
3.5 Herpes Zoster Infection Treatment Key Players Head office and Area Served
3.6 Key Players Herpes Zoster Infection Treatment Product Solution and Service
3.7 Date of Enter into Herpes Zoster Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Herpes Zoster Infection Treatment Breakdown Data by Type
4.1 Global Herpes Zoster Infection Treatment Historic Market Size by Type (2018-2023)
4.2 Global Herpes Zoster Infection Treatment Forecasted Market Size by Type (2024-2033)
5 Herpes Zoster Infection Treatment Breakdown Data by Application
5.1 Global Herpes Zoster Infection Treatment Historic Market Size by Application (2018-2023)
5.2 Global Herpes Zoster Infection Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Herpes Zoster Infection Treatment Market Size (2018-2033)
6.2 North America Herpes Zoster Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Herpes Zoster Infection Treatment Market Size by Country (2018-2023)
6.4 North America Herpes Zoster Infection Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Herpes Zoster Infection Treatment Market Size (2018-2033)
7.2 Europe Herpes Zoster Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Herpes Zoster Infection Treatment Market Size by Country (2018-2023)
7.4 Europe Herpes Zoster Infection Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Herpes Zoster Infection Treatment Market Size (2018-2033)
8.2 Asia-Pacific Herpes Zoster Infection Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Herpes Zoster Infection Treatment Market Size (2018-2033)
9.2 Latin America Herpes Zoster Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Herpes Zoster Infection Treatment Market Size by Country (2018-2023)
9.4 Latin America Herpes Zoster Infection Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Herpes Zoster Infection Treatment Market Size (2018-2033)
10.2 Middle East & Africa Herpes Zoster Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Herpes Zoster Infection Treatment Introduction
11.1.4 Bausch Health Revenue in Herpes Zoster Infection Treatment Business (2018-2023)
11.1.5 Bausch Health Recent Development
11.2 Camber Pharmaceuticals
11.2.1 Camber Pharmaceuticals Company Detail
11.2.2 Camber Pharmaceuticals Business Overview
11.2.3 Camber Pharmaceuticals Herpes Zoster Infection Treatment Introduction
11.2.4 Camber Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2018-2023)
11.2.5 Camber Pharmaceuticals Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Herpes Zoster Infection Treatment Introduction
11.3.4 Novartis Revenue in Herpes Zoster Infection Treatment Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Detail
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Herpes Zoster Infection Treatment Introduction
11.4.4 Teva Pharmaceutical Revenue in Herpes Zoster Infection Treatment Business (2018-2023)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Herpes Zoster Infection Treatment Introduction
11.5.4 Abbott Revenue in Herpes Zoster Infection Treatment Business (2018-2023)
11.5.5 Abbott Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Herpes Zoster Infection Treatment Introduction
11.6.4 Merck Revenue in Herpes Zoster Infection Treatment Business (2018-2023)
11.6.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Herpes Zoster Infection Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral
Table 3. Key Players of Topical
Table 4. Global Herpes Zoster Infection Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Herpes Zoster Infection Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Herpes Zoster Infection Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Herpes Zoster Infection Treatment Market Share by Region (2018-2023)
Table 8. Global Herpes Zoster Infection Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Herpes Zoster Infection Treatment Market Share by Region (2024-2033)
Table 10. Herpes Zoster Infection Treatment Market Trends
Table 11. Herpes Zoster Infection Treatment Market Drivers
Table 12. Herpes Zoster Infection Treatment Market Challenges
Table 13. Herpes Zoster Infection Treatment Market Restraints
Table 14. Global Herpes Zoster Infection Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Herpes Zoster Infection Treatment Market Share by Players (2018-2023)
Table 16. Global Top Herpes Zoster Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoster Infection Treatment as of 2022)
Table 17. Ranking of Global Top Herpes Zoster Infection Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Herpes Zoster Infection Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Herpes Zoster Infection Treatment Product Solution and Service
Table 21. Date of Enter into Herpes Zoster Infection Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Herpes Zoster Infection Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Herpes Zoster Infection Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Herpes Zoster Infection Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Herpes Zoster Infection Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Herpes Zoster Infection Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Herpes Zoster Infection Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Herpes Zoster Infection Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Herpes Zoster Infection Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Herpes Zoster Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Herpes Zoster Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Herpes Zoster Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Herpes Zoster Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Herpes Zoster Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Herpes Zoster Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Herpes Zoster Infection Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Herpes Zoster Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Herpes Zoster Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Herpes Zoster Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Herpes Zoster Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Bausch Health Company Detail
Table 47. Bausch Health Business Overview
Table 48. Bausch Health Herpes Zoster Infection Treatment Product
Table 49. Bausch Health Revenue in Herpes Zoster Infection Treatment Business (2018-2023) & (US$ Million)
Table 50. Bausch Health Recent Development
Table 51. Camber Pharmaceuticals Company Detail
Table 52. Camber Pharmaceuticals Business Overview
Table 53. Camber Pharmaceuticals Herpes Zoster Infection Treatment Product
Table 54. Camber Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2018-2023) & (US$ Million)
Table 55. Camber Pharmaceuticals Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Herpes Zoster Infection Treatment Product
Table 59. Novartis Revenue in Herpes Zoster Infection Treatment Business (2018-2023) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Teva Pharmaceutical Company Detail
Table 62. Teva Pharmaceutical Business Overview
Table 63. Teva Pharmaceutical Herpes Zoster Infection Treatment Product
Table 64. Teva Pharmaceutical Revenue in Herpes Zoster Infection Treatment Business (2018-2023) & (US$ Million)
Table 65. Teva Pharmaceutical Recent Development
Table 66. Abbott Company Detail
Table 67. Abbott Business Overview
Table 68. Abbott Herpes Zoster Infection Treatment Product
Table 69. Abbott Revenue in Herpes Zoster Infection Treatment Business (2018-2023) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Merck Company Detail
Table 72. Merck Business Overview
Table 73. Merck Herpes Zoster Infection Treatment Product
Table 74. Merck Revenue in Herpes Zoster Infection Treatment Business (2018-2023) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Zoster Infection Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Herpes Zoster Infection Treatment Market Share by Type: 2022 VS 2033
Figure 3. Oral Features
Figure 4. Topical Features
Figure 5. Global Herpes Zoster Infection Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Herpes Zoster Infection Treatment Market Share by Application: 2022 VS 2033
Figure 7. Clinics Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Diagnostic centers Case Studies
Figure 10. Home Care Case Studies
Figure 11. Herpes Zoster Infection Treatment Report Years Considered
Figure 12. Global Herpes Zoster Infection Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Herpes Zoster Infection Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Herpes Zoster Infection Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Herpes Zoster Infection Treatment Market Share by Players in 2022
Figure 16. Global Top Herpes Zoster Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoster Infection Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Herpes Zoster Infection Treatment Revenue in 2022
Figure 18. North America Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Herpes Zoster Infection Treatment Market Share by Country (2018-2033)
Figure 20. United States Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Herpes Zoster Infection Treatment Market Share by Country (2018-2033)
Figure 24. Germany Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Herpes Zoster Infection Treatment Market Share by Region (2018-2033)
Figure 32. China Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Herpes Zoster Infection Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Herpes Zoster Infection Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Herpes Zoster Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Bausch Health Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2018-2023)
Figure 47. Camber Pharmaceuticals Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2018-2023)
Figure 49. Teva Pharmaceutical Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2018-2023)
Figure 50. Abbott Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed